Overview

Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Identification and evaluation of endogenous markers for the assessment of CYP3A activity using metabolomics.
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Ministry of Education Science and Technology, Korea
Treatments:
Midazolam